Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.24 USD | +20.29% | +53.64% | -56.04% |
05-10 | Annovis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Annovis Bio, Inc. Announces Unblinding of the Buntanetap Phase III Data in Parkinson?s Disease | CI |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- MarketScreener Strategies